Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
J Thorac Dis. 2014 Feb;6(2):118-25. doi: 10.3978/j.issn.2072-1439.2013.12.49.
It is well-known that chronic administration of β2AR agonists can induce β2AR desensitization. Our previous study showed that Rho guanine nucleotide dissociation inhibitor 2 (RhoGDI2) overexpression induced beta-2 adrenergic receptor (β2AR) desensitization in airway smooth muscle cells. The purpose of this study was to further study the function of RhoGDI2 in β2AR desensitization by β2AR desensitization mouse model.
Studies were performed using a β2AR desensitization mice model induced by salbutamol. The mice were randomly divided into five groups (n=45): RhoGDI2 overexpression group (n=10); RhoGDI2 siRNA group (n=10); empty viral vector group (n=10); experimental control group (n=10); blank control group-without any drug treatment (n=5). The first four groups were used the same methods and the same dose to establish β2AR desensitization mice model by salbutamol. The first three groups that salbutamol-treated were used for intratracheal delivery of lentiviral vectors. Airway hyperreactivity was measured through a whole-body plethysmograph system. RhoGDI2, β2AR, GRK2 mRNA and protein expression levels were then detected by RT-PCR and western blot analyses in fresh lung tissues. As well as the activity of GRK was assessed by light-dependent phosphorylation of rhodopsin.
We successfully constructed β2AR desensitization mouse model. As expected, airway responsiveness after inhaling acetylcholine chloride (Ach) was markedly increased in the RhoGDI2 overexpression group compared to experimental control group and blank control group when concentrations of Ach was 45 mg/mL (all P<0.05), while, it was markedly decreased in the RhoGDI2 siRNA group compared to experimental control group (P<0.05). RhoGDI2, GRK2 expressions and GRK enzymatic activity were significantly increased in RhoGDI2 overexpression group compared to experimental control group and blank control group (all P<0.05). RhoGDI2, GRK2 expressions and GRK enzymatic activity were significantly decreased in RhoGDI2 siRNA group compared to experimental control group and blank control group (all P<0.05). Conversely, β2AR expression were significantly lower in RhoGDI2 overexpression group compared to experimental control group and blank control group (all P<0.05), exhibiting an inverse correlation with RhoGDI2 expression.
To sum up, our present studies found that RhoGDI2 might induce β2AR desensitization and GRK2 might take part in RhoGDI2-mediated β2AR desensitization.
众所周知,慢性给予β2AR 激动剂可诱导β2AR 脱敏。我们之前的研究表明,Rho 鸟嘌呤核苷酸解离抑制剂 2(RhoGDI2)过表达可诱导气道平滑肌细胞中的β-2 肾上腺素能受体(β2AR)脱敏。本研究旨在通过β2AR 脱敏小鼠模型进一步研究 RhoGDI2 在β2AR 脱敏中的功能。
使用沙丁胺醇诱导的β2AR 脱敏小鼠模型进行研究。将小鼠随机分为五组(n=45):RhoGDI2 过表达组(n=10);RhoGDI2 siRNA 组(n=10);空载病毒载体组(n=10);实验对照组(n=10);空白对照组-无任何药物处理(n=5)。前四组采用相同的方法和相同的沙丁胺醇剂量建立β2AR 脱敏小鼠模型。沙丁胺醇处理的前三组采用慢病毒载体经气管内给药。通过全身 plethysmograph 系统测量气道高反应性。然后通过 RT-PCR 和 Western blot 分析检测新鲜肺组织中的 RhoGDI2、β2AR、GRK2 mRNA 和蛋白表达水平。以及通过视黄醛的光依赖性磷酸化评估 GRK 的活性。
我们成功构建了β2AR 脱敏小鼠模型。正如预期的那样,与实验对照组和空白对照组相比,吸入氯化乙酰胆碱(Ach)后 RhoGDI2 过表达组的气道反应性明显增加,当 Ach 浓度为 45mg/ml 时(均 P<0.05),而 RhoGDI2 siRNA 组与实验对照组相比则明显降低(P<0.05)。与实验对照组和空白对照组相比,RhoGDI2 过表达组 RhoGDI2、GRK2 表达和 GRK 酶活性明显增加(均 P<0.05)。与实验对照组和空白对照组相比,RhoGDI2 siRNA 组 RhoGDI2、GRK2 表达和 GRK 酶活性明显降低(均 P<0.05)。相反,与实验对照组和空白对照组相比,RhoGDI2 过表达组β2AR 表达明显降低(均 P<0.05),与 RhoGDI2 表达呈负相关。
综上所述,本研究发现 RhoGDI2 可能诱导β2AR 脱敏,GRK2 可能参与 RhoGDI2 介导的β2AR 脱敏。